Advisory Council for the Elimination of Tuberculosis (ACET), 66936-66937 [2013-26633]
Download as PDF
<![CDATA[
66936
Federal Register / Vol. 78, No. 216 / Thursday, November 7, 2013 / Notices
the National Breast and Cervical Cancer
Early Detection Program (NBCCEDP).
Currently, the NBCCEDP funds 67
grantees including all 50 states, the
District of Columbia, 5 U.S. territories,
and 11 American Indian/Alaska Native
tribes or tribal organizations. Grantees
provide screening services for breast
and cervical cancer to low-income,
uninsured, and underinsured women
who otherwise would not have access to
screening.
Since 1991, NBCCEDP-funded
grantees have served more than 4.3
million women, provided more than
10.7 million breast and cervical cancer
screening examinations, and diagnosed
more than 56,662 breast cancers, 3,206
invasive cervical cancers, and 152,470
premalignant cervical lesions, of which
41% were high-grade. As a
comprehensive, organized screening
program, the NBCCEDP supports
activities including program
management, partnership development,
public education and targeted outreach,
screening and diagnostic services,
patient navigation, quality assurance
and quality improvement, professional
development, data management and
utilization, and program monitoring and
evaluation. For clinical service delivery,
grantees fund health care providers in
their state/territory/tribe to deliver
breast and cervical cancer screening,
diagnostic evaluation, and treatment
referrals for women diagnosed with
cancer.
CDC issued a new Funding
Opportunity Announcement (FOA) to
support a new 5-year cooperative
agreement for the NBCCEDP effective
July 2012. This new FOA begins to shift
the NBCCEDP from a focus on direct
service provision to implementation of
expanded evidence-based activities
intended to increase rates of breast and
cervical cancer screening at the
population level. Though NBCCEDP
grantees continue to provide breast and
cervical cancer screening for uninsured
and underinsured women, CDC is
encouraging the implementation of
strategies to increase screening rates
beyond that of program-eligible women.
CDC plans to implement an annual
survey of NBCCEDP program directors
in order to assess program
implementation, particularly related to
these expanded population-based
efforts. The Web-based survey includes
questions on respondent background,
program activities, clinical service
delivery, monitoring and evaluation,
partnerships, training and technical
assistance needs, and program
management. Questions are of various
types including dichotomous and
multiple response. The estimated
burden per response is 45 minutes.
This assessment will enable CDC to
gauge its progress in meeting NBCCEDP
program goals, identify implementation
activities, monitor program transition to
efforts aimed at impacting populationbased screening, identify technical
assistance needs of state, tribe and
territorial health department cancer
control programs, and identify
implementation models with potential
to expand and transition to new settings
to increase program impact and reach.
The assessment will identify successful
activities that should be maintained,
replicated, or expanded as well as
provide insight into areas that need
improvement.
OMB approval is requested for three
years. Participation is voluntary and
there are no costs to respondents other
than their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondent
Form name
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hr)
Total burden
(in hr)
NBCCEDP Program Directors.
CDC National Breast and Cervical Cancer Early
Detection Program (NBCCEDP) Grantee Survey of Program Implementation.
67
1
45/60
50
LeRoy Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2013–26671 Filed 11–6–13; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
This document may be
obtained at the following link:
www.cdc.gov/niosh/docs/2014-100/.
tkelley on DSK3SPTVN1PROD with NOTICES
G.
Scott Dotson, Ph.D. CIH, NIOSH
Education and Information Division,
Taft Laboratories Building, 4676
Columbia Parkway, Cincinnati, Ohio,
45226. (513) 533–8540.
Dated: November 1, 2013.
John Howard,
Director, National Institute for Occupational
Safety and Health, Centers for Disease Control
and Prevention.
[FR Doc. 2013–26678 Filed 11–6–13; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Council for the Elimination of
Tuberculosis (ACET)
FOR FURTHER INFORMATION CONTACT:
Issuance of Final Guidance Publication
National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC),
Department of Health and Human
Services (HHS).
AGENCY:
16:24 Nov 06, 2013
The National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC),
announces the availability of the
following publication: ‘‘Current
Intelligence Bulletin 66—Derivation of
Immediately Dangerous to Life or Health
(IDLH) Values’’ [NIOSH 2014–100].
SUMMARY:
ADDRESSES:
[Docket Number NIOSH–156]
VerDate Mar<15>2010
Notice of issuance of final
guidance publication.
ACTION:
Jkt 232001
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
Time and Date: 11:00 a.m.–3:30 p.m.,
December 3, 2013
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
E:\FR\FM\07NON1.SGM
07NON1
Federal Register / Vol. 78, No. 216 / Thursday, November 7, 2013 / Notices
Place: This meeting is accessible by Web
conference. Toll-free +1 (866) 844–9416,
Participant Code: 2727032.
For Participants:
URL: https://www.mymeetings.com/nc/
join/.
Conference number: PW5636201.
Audience passcode: 2727032.
Participants can join the event directly at:
https://www.mymeetings.com/nc/
join.php?i=PW5636201&p=2727032&t=c.
Status: Open to the public limited only by
web conference.
Participation by Web conference is limited
by the number of 100 ports available.
Purpose: This council advises and makes
recommendations to the Secretary of Health
and Human Services, the Assistant Secretary
for Health, and the Director, CDC, regarding
the elimination of tuberculosis. Specifically,
the Council makes recommendations
regarding policies, strategies, objectives, and
priorities; addresses the development and
application of new technologies; and reviews
the extent to which progress has been made
toward eliminating tuberculosis.
Matters To Be Discussed: Agenda items
include the following topics: (1) ACET
Chair’s report to the Secretary; (2) ACET
Essential Components Workgroup Update; (3)
Drug Shortages Update; and (4) other
tuberculosis-related issues.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Margie Scott-Cseh, CDC, 1600 Clifton Road,
NE., M/S E–07, Atlanta, Georgia 30333,
Telephone: (404) 639–8317; Email: zkr7@
cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register Notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Catherine Ramadei,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention (CDC).
Notice will be provided if the meeting
is rescheduled in accordance with
section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92–463).
This notice is published less than the
required 15 days prior to the start of the
announced meeting, in accordance with
Section 102–3.150(b) of the GSA Final
Rule (2001) that allows for exceptions to
the meeting notification time
requirement. Section 102–3.150(b) states
the following: ‘‘In exceptional
circumstances, the agency or an
independent Presidential advisory
committee may give less than 15
calendar days’ notice, provided that the
reasons for doing so are included in the
advisory committee meeting notice
published in the Federal Register.’’
In this case, the agency is giving less
than 15 days’ notice due to the recent
furlough status of United States Federal
Government, including the U.S.
Department of Health and Human
Services, Centers for Disease Control
and Prevention, from October 1–16,
2013.
Contact Person for More Information:
Joan F. Karr, Ph.D., Scientific Review
Officer, CDC/NIOSH, 1600 Clifton Road,
Mailstop E–74, Atlanta, Georgia 30333,
Telephone: (404) 498–2506. The
Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Catherine Ramadei,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2013–26650 Filed 11–6–13; 8:45 am]
[FR Doc. 2013–26633 Filed 11–6–13; 8:45 am]
BILLING CODE 4163–18–P
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
tkelley on DSK3SPTVN1PROD with NOTICES
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
Notice of Cancellation: This notice
concerns ‘‘Occupational Safety and
Health Training Project Grants (T03),
Funding Opportunity Announcement
PAR–10–288, initial review, published
in the Federal Register on October 2,
2013 (FR Volume 78, Number 191, Page
60877). This SEP, scheduled to convene
on November 6, 2013, is canceled.
VerDate Mar<15>2010
16:24 Nov 06, 2013
Jkt 232001
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below
concerns Capacity Building Assistance
for High Impact HIV Prevention,
Funding Opportunity Announcement
(FOA) PS14–1403, Initial Review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned SEP:
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
66937
Times and Dates: 8:00 a.m.–8:00 p.m.,
December 10–12, 2013 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the initial review, discussion, and
evaluation of applications received in
response to ‘‘Capacity Building Assistance
for High Impact HIV Prevention’’ FOA PS14–
1403.
Contact Person for More Information:
Harriette A. Lynch, Public Health Analyst,
CDC, 1600 Clifton Road, NE., Mailstop E07,
Atlanta, Georgia 30333, Telephone: (404)
718–8837. The Director, Management
Analysis and Services Office, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for both
the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Catherine Ramadei,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2013–26635 Filed 11–6–13; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below
concerns Occupational Safety and
Health Training Project Grants (T03),
PAR–10–288, initial review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date: 12:00 p.m.–5:00 p.m.,
January 8, 2014 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the initial review, discussion, and
evaluation of applications received in
response to ‘‘Occupational Safety and Health
Training Project Grants (T03), PAR–10–288.’’
Contact Person for More Information: Joan
F. Karr, Ph.D., Scientific Review Officer,
CDC/NIOSH, 1600 Clifton Road, Mailstop E–
74, Atlanta, Georgia 30333, Telephone:
E:\FR\FM\07NON1.SGM
07NON1
]]>Agencies
[Federal Register Volume 78, Number 216 (Thursday, November 7, 2013)]
[Notices]
[Pages 66936-66937]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-26633]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Council for the Elimination of Tuberculosis (ACET)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC), announces the following meeting of the aforementioned
committee:
Time and Date: 11:00 a.m.-3:30 p.m., December 3, 2013
[[Page 66937]]
Place: This meeting is accessible by Web conference. Toll-free
+1 (866) 844-9416, Participant Code: 2727032.
For Participants:
URL: https://www.mymeetings.com/nc/join/.
Conference number: PW5636201.
Audience passcode: 2727032.
Participants can join the event directly at: https://www.mymeetings.com/nc/join.php?i=PW5636201&p=2727032&t=c.
Status: Open to the public limited only by web conference.
Participation by Web conference is limited by the number of 100
ports available.
Purpose: This council advises and makes recommendations to the
Secretary of Health and Human Services, the Assistant Secretary for
Health, and the Director, CDC, regarding the elimination of
tuberculosis. Specifically, the Council makes recommendations
regarding policies, strategies, objectives, and priorities;
addresses the development and application of new technologies; and
reviews the extent to which progress has been made toward
eliminating tuberculosis.
Matters To Be Discussed: Agenda items include the following
topics: (1) ACET Chair's report to the Secretary; (2) ACET Essential
Components Workgroup Update; (3) Drug Shortages Update; and (4)
other tuberculosis-related issues.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Margie Scott-Cseh, CDC,
1600 Clifton Road, NE., M/S E-07, Atlanta, Georgia 30333, Telephone:
(404) 639-8317; Email: zkr7@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register Notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
Catherine Ramadei,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention (CDC).
[FR Doc. 2013-26633 Filed 11-6-13; 8:45 am]
BILLING CODE 4163-18-P
